I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 27% ± 11% | |
| neuron | 6 studies | 27% ± 9% | |
| CD8-positive, alpha-beta T cell | 6 studies | 24% ± 10% | |
| CD4-positive, alpha-beta T cell | 5 studies | 31% ± 14% | |
| retinal ganglion cell | 5 studies | 68% ± 28% | |
| hematopoietic precursor cell | 4 studies | 22% ± 8% | |
| GABAergic neuron | 4 studies | 28% ± 4% | |
| glutamatergic neuron | 4 studies | 36% ± 8% | |
| natural killer cell | 4 studies | 23% ± 6% | |
| regulatory T cell | 4 studies | 24% ± 8% | |
| conventional dendritic cell | 3 studies | 19% ± 1% | |
| type II pneumocyte | 3 studies | 35% ± 16% | |
| ciliated cell | 3 studies | 22% ± 9% | |
| erythroblast | 3 studies | 30% ± 12% | |
| dendritic cell | 3 studies | 27% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 30% ± 13% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 29% ± 7% | |
| basal cell | 3 studies | 33% ± 8% | |
| astrocyte | 3 studies | 22% ± 6% | |
| oligodendrocyte | 3 studies | 22% ± 5% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 29% ± 9% | |
| hepatocyte | 3 studies | 49% ± 29% |
